News | News By Subject | News by Disease News By Date | Search News

Gastroparesis News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News

News from Around the Web
No News Posted on that date

Press Releases
Rhythm Presents Positive Phase 2 Study Results For Ghrelin Prokinetic Relamorelin (RM-131) In Diabetic Gastroparesis     5/6/2014
Theravance, Inc. (THRX) and Alfa Wasserman Announce Initiation of Phase 2 Study With Velusetrag for Gastroparesis     1/9/2013
Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Diabetic Gastroparesis     5/22/2012
Tranzyme Pharma to Present TZP-102 Phase 2 Data Showing Decrease in Severity of Symptoms of Gastroparesis     10/18/2010
Tranzyme Pharma to Present Ulimorelin Data Showing Reduction in Daily Vomiting in Patients with Diabetic Gastroparesis     8/25/2010
Tranzyme Pharma Announces Positive Results from Phase 2 Study of Oral TZP-102 (Ghrelin Agonist) in Patients with Diabetic Gastroparesis     6/29/2010
Tranzyme Pharma Receives FDA Fast Track Designation for its Novel Ghrelin Agonist, TZP-101, for the Treatment of Severe Gastroparesis     7/12/2007
Tranzyme Pharma Expands Clinical Program Of Its Novel Ghrelin Agonist, TZP-101, To Include Patients With Gastroparesis     9/21/2006
XenoPort, Inc. (XNPT) Announces Results From An Initial Phase 1 Clinical Trial Of XP19986 - A Potential New Treatment For Gastroesophageal Reflux Disease (GERD) And Spasticity     7/11/2005